610 not checked

3SBio

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
2 active
2 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Asthma (2 trials)
Main trialPhase 3
“The primary objective of the study is to evaluate the efficacy and safety of 610 in Chinese adults with severe asthma.”In the company’s words, NCT06323213 on ClinicalTrials.gov

Other drugs for Asthma

All 58 drugs for Asthma

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 3Recruiting Feb 2027 Efficacy and Safety Study of 610 in Patients With Severe Asthma
Phase 2Active, not recruiting Feb 2027 A Phase IIb Study of 610 in Participants With Severe Eosinophilic Asthma
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow 610

Following is part of Solo: you see every change to 610 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in